Abnormal hepatic energy homeostasis in type 2 diabetes
- PMID: 19637187
- DOI: 10.1002/hep.23093
Abnormal hepatic energy homeostasis in type 2 diabetes
Abstract
Increased hepatocellular lipids relate to insulin resistance and are typical for individuals with type 2 diabetes mellitus (T2DM). Steatosis and T2DM have been further associated with impaired muscular adenosine triphosphate (ATP) turnover indicating reduced mitochondrial fitness. Thus, we tested the hypothesis that hepatic energy metabolism could be impaired even in metabolically well-controlled T2DM. We measured hepatic lipid volume fraction (HLVF) and absolute concentrations of gammaATP, inorganic phosphate (Pi), phosphomonoesters and phosphodiesters using noninvasive (1)H/ (31)P magnetic resonance spectroscopy in individuals with T2DM (58 +/- 6 years, 27 +/- 3 kg/m (2)), and age-matched and body mass index-matched (mCON; 61 +/- 4 years, 26 +/- 4 kg/m (2)) and young lean humans (yCON; 25 +/- 3 years, 22 +/- 2 kg/m (2), P < 0.005, P < 0.05 versus T2DM and mCON). Insulin-mediated whole-body glucose disposal (M) and endogenous glucose production (iEGP) were assessed during euglycemic-hyperinsulinemic clamps. Individuals with T2DM had 26% and 23% lower gammaATP (1.68 +/- 0.11; 2.26 +/- 0.20; 2.20 +/- 0.09 mmol/L; P < 0.05) than mCON and yCON individuals, respectively. Further, they had 28% and 31% lower Pi than did individuals from the mCON and yCON groups (0.96 +/- 0.06; 1.33 +/- 0.13; 1.41 +/- 0.07 mmol/L; P < 0.05). Phosphomonoesters, phosphodiesters, and liver aminotransferases did not differ between groups. HLVF was not different between those from the T2DM and mCON groups, but higher (P = 0.002) than in those from the yCON group. T2DM had 13-fold higher iEGP than mCON (P < 0.05). Even after adjustment for HLVF, hepatic ATP and Pi related negatively to hepatic insulin sensitivity (iEGP) (r =-0.665, P = 0.010, r =-0.680, P = 0.007) but not to whole-body insulin sensitivity.
Conclusion: These data suggest that impaired hepatic energy metabolism and insulin resistance could precede the development of steatosis in individuals with T2DM.
Similar articles
-
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.J Am Coll Cardiol. 2010 Jul 13;56(3):225-33. doi: 10.1016/j.jacc.2010.02.049. J Am Coll Cardiol. 2010. PMID: 20620743
-
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.Gastroenterology. 2007 Aug;133(2):496-506. doi: 10.1053/j.gastro.2007.04.068. Epub 2007 May 1. Gastroenterology. 2007. PMID: 17681171
-
Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus.J Hepatol. 2021 May;74(5):1028-1037. doi: 10.1016/j.jhep.2020.11.030. Epub 2020 Nov 28. J Hepatol. 2021. PMID: 33259845
-
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.Mol Cell Endocrinol. 2013 Oct 15;379(1-2):35-42. doi: 10.1016/j.mce.2013.06.002. Epub 2013 Jun 12. Mol Cell Endocrinol. 2013. PMID: 23770462 Review.
-
Metabolites as regulators of insulin sensitivity and metabolism.Nat Rev Mol Cell Biol. 2018 Oct;19(10):654-672. doi: 10.1038/s41580-018-0044-8. Nat Rev Mol Cell Biol. 2018. PMID: 30104701 Free PMC article. Review.
Cited by
-
NAFLD and diabetes mellitus.Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):32-42. doi: 10.1038/nrgastro.2016.147. Epub 2016 Oct 12. Nat Rev Gastroenterol Hepatol. 2017. PMID: 27729660 Review.
-
Use of in vivo magnetic resonance spectroscopy for studying metabolic diseases.Exp Mol Med. 2015 Feb 6;47(2):e139. doi: 10.1038/emm.2014.101. Exp Mol Med. 2015. PMID: 25656949 Free PMC article. Review.
-
Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice.J Biol Chem. 2021 Jan-Jun;296:100498. doi: 10.1016/j.jbc.2021.100498. Epub 2021 Mar 2. J Biol Chem. 2021. PMID: 33667544 Free PMC article.
-
PANX1-mediated ATP release confers FAM3A's suppression effects on hepatic gluconeogenesis and lipogenesis.Mil Med Res. 2024 Jun 27;11(1):41. doi: 10.1186/s40779-024-00543-6. Mil Med Res. 2024. PMID: 38937853 Free PMC article.
-
The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake.Br J Clin Pharmacol. 2014 Jan;77(1):21-30. doi: 10.1111/bcp.12102. Br J Clin Pharmacol. 2014. PMID: 23452341 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous